| Year |
Citation |
Score |
| 2018 |
Liu TT, Ewald JA, Ricke EA, Bell R, Collins C, Ricke WA. Modeling Human Prostate Cancer Progression in vitro. Carcinogenesis. PMID 30590461 DOI: 10.1093/Carcin/Bgy185 |
0.369 |
|
| 2013 |
Desotelle J, Truong M, Ewald J, Weeratunga P, Yang B, Huang W, Jarrard D. CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer Journal of Urology. 189: 329-335. PMID 23174249 DOI: 10.1016/J.Juro.2012.08.188 |
0.371 |
|
| 2013 |
Ewald JA, Desotelle JA, Church DR, Yang B, Huang W, Laurila TA, Jarrard DF. Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo Prostate. 73: 337-345. PMID 22911222 DOI: 10.1002/Pros.22571 |
0.339 |
|
| 2012 |
Shankaran H, Zhang Y, Chrisler WB, Ewald JA, Wiley HS, Resat H. Integrated experimental and model-based analysis reveals the spatial aspects of EGFR activation dynamics Molecular Biosystems. 8: 2868-2882. PMID 22952062 DOI: 10.1039/C2Mb25190F |
0.466 |
|
| 2012 |
Ewald JA, Jarrard DF. Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Translational Oncology. 5: 278-87. PMID 22937180 DOI: 10.1593/Tlo.12181 |
0.402 |
|
| 2011 |
Ewald J, Desotelle J, Church D, Laurila T, Jarrard D. 1445 ANDROGEN DEPRIVATION INDUCES A DELAYED SENESCENT PHENOTYPE IN PROSTATE CANCER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1358 |
0.341 |
|
| 2010 |
Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. Journal of the National Cancer Institute. 102: 1536-46. PMID 20858887 DOI: 10.1093/Jnci/Djq364 |
0.326 |
|
| 2010 |
Ewald J, Desotelle J, Hoffman FM, Jarrard D. 1185 SENESCENCE AS CYTOSTATIC THERAPY: DRUG-INDUCED SENESCENCE IN PROSTATE CANCER CELLS REQUIRES SKP2-REGULATED P27KIP1 EXPRESSION Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.686 |
0.381 |
|
| 2009 |
Ewald JA, Peters N, Desotelle JA, Hoffmann FM, Jarrard DF. A high-throughput method to identify novel senescence-inducing compounds. Journal of Biomolecular Screening. 14: 853-8. PMID 19641224 DOI: 10.1177/1087057109340314 |
0.316 |
|
| 2008 |
Fu VX, Dobosy JR, Desotelle JA, Almassi N, Ewald JA, Srinivasan R, Berres M, Svaren J, Weindruch R, Jarrard DF. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Research. 68: 6797-802. PMID 18701505 DOI: 10.1158/0008-5472.Can-08-1714 |
0.369 |
|
| 2008 |
Ewald JA, Desotelle JA, Almassi N, Jarrard DF. Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo British Journal of Cancer. 98: 1244-1249. PMID 18349844 DOI: 10.1038/Sj.Bjc.6604288 |
0.407 |
|
| 2008 |
Ewald JA, Laurila T, Almassi N, Dosetelle JA, Jarrard DF. A NOVEL HIGH THROUGHPUT SCREEN IDENTIFIES POTENT SENESCENCE-INDUCING ACTIVITY OF DIAZIQUONE (AZQ) IN PROSTATE CANCER CELLS Journal of Urology. 179: 390-391. DOI: 10.1016/S0022-5347(08)61143-X |
0.359 |
|
| 2003 |
Resat H, Ewald JA, Dixon DA, Wiley HS. An integrated model of epidermal growth factor receptor trafficking and signal transduction. Biophysical Journal. 85: 730-43. PMID 12885624 DOI: 10.1016/S0006-3495(03)74516-0 |
0.376 |
|
| 2003 |
Ewald JA, Wilkinson JC, Guyer CA, Staros JV. Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells. Experimental Cell Research. 282: 121-31. PMID 12531698 DOI: 10.1016/S0014-4827(02)00014-9 |
0.574 |
|
| 2001 |
Ewald JA, Coker KJ, Price JO, Staros JV, Guyer CA. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor. Experimental Cell Research. 268: 262-73. PMID 11478852 DOI: 10.1006/Excr.2001.5271 |
0.595 |
|
| Show low-probability matches. |